SOURCE: Solos Endoscopy, Inc.

February 22, 2007 08:30 ET

Solos Endoscopy, Inc. Launches Breast Products at the 24th Annual Miami Breast Cancer Conference

BOSTON, MA -- (MARKET WIRE) -- February 22, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) is pleased to announce that representatives of the Company are currently attending the 24th Annual Miami Breast Cancer Conference. This conference has been designed to provide medical professionals with a comprehensive update on the latest research and medical advances in the treatment of breast cancer. The conference incorporates the newest technologies and procedures in order for today's physicians to have the most modern tools to treat their patients.

The organizers of Annual Breast Cancer Conference are expecting an estimated 1,100 doctors and medical professionals from around the world to attend. In addition, the major contributors for the event are comprised of some of the largest medical and pharmaceutical companies in the world including Bristol-Myers Squibb, AstraZeneca, Pfizer Oncology, and GlaxoSmithKline. For information about the conference, please visit

"This is an ideal venue for us to showcase our advanced non-invasive products to the international medical market. We expect to create many valuable relationships with the medical professionals who are actively fighting the battle against breast cancer," stated Joe Gassman, Vice President of International Sales for Solos Endoscopy, Inc.

Solos Endoscopy, Inc. recently announced that the Company's board of directors has approved a new acquisition and merger strategy. Solos Endoscopy is currently considering several companies in the medical industry. The Company will look to expand their presence throughout the world while constantly increasing their market share.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit and download your FREE copy of Big Apple ComPro.

Contact Information